Skip to content
southeast-life-sciences-women

Women@SLS Advisory Board

Women@SLS is a group dedicated to enhancing opportunities for women in the life scienceindustry. The Advisory Board represents an impressive group of women from industry, medicine, and academia that are passionate about supporting women at all levels in their careers.  

womens-board-allyson-bower-willner
Marketing Director,Strategic Accounts – Molnlycke Healthcare

Allyson Bower-Willner

womens-board-sherry-farrugia
Managing Director – Health Research Partnerships at Georgia Tech

Sherry Farrugia

womens-board-jessee-goodwin
Chief Innovation Officer, Medical University of South Carolina

Dr. Jesse Goodwin

womens-board-grace-powers
Vice President of Regulatory Affairs – Brookhaven Medical

Grace Powers

Dr. Lauren Rashford

Dr. Esra Roan

woåmens-board-meredith-struby
Principal – Meunier Carlin & Curfman

Meredith Struby

womens-board-jayne-morgan
Director of Cardiovascular Research – Piedmont Heart Institute

Jayne Morgan, Co-Chair

womens-board-allyson-bower-willner

Marketing Director,Strategic Accounts – Molnlycke Healthcare

Allyson Bower-Willner

Ms. Bower-Willner has over 20 years of diverse medical device, NGS (Next Generation Sequencing), biologics and pharmaceutical experience. Her experience ranges from pre-revenue start-ups to multinational Fortune 100 companies, with many in between. Allyson currently serves as the Marketing Director, Strategic Accounts, for Molnlycke Healthcare.

In addition to her work at small medical device companies in the Atlanta area, she previously held roles at Halyard Health, CardioMEMS (now St. Jude Medical), CR Bard and at PRTM (Pittiglio, Rabin, Todd and McGrath, now Price Waterhouse Cooper). Her experience encompasses upstream and downstream marketing, strategy, product development, manufacturing, and quality assurance. Her passion is bringing new and innovative technologies to market. Allyson is a graduate of Rensselaer Polytechnic Institute and Rutgers Graduate School of Management.

womens-board-sherry-farrugia

Managing Director – Health Research Partnerships at Georgia Tech

Sherry Farrugia

Sherry Farrugia is the Managing Director for Health Research Partnerships at Georgia Tech and Director of the Pediatric Technology Center, a research collaboration between Georgia Tech and Children’s Healthcare of Atlanta. In this dual role she works to build and sustain public-private partnerships, and spends half her time at Georgia Tech and the other half at Children’s Healthcare of Atlanta where she manages the multi- million research portfolio. Farrugia has nearly 25 years experience in the Health IT field, working in data analytics, data visualization, and clinical and financial outcomes. She owned a health IT company that she sold to McKesson HBOC, and was involved in several other successful start up companies.

Before coming to Georgia Tech she owned a healthcare consulting company focusing on predictive health and risk mitigation in the area of chronic disease prediction, prevention, and management.

Farrugia is a member of: TAG Health Board, Gwinnett Tech HIT Advisory Board, an active member of the Bioscience HIT council at the Metro Atlanta Chamber of Commerce, Health Connect South Advisory Board, HIT Leadership Summit Innovation Committee, HIMSS, Atlanta Ronald McDonald House Charities Advisory Council, and Emory Board of Visitors. Ms. Farrugia received her B.S. in Chemistry with a minor in Physics from Auburn University.

womens-board-jessee-goodwin

Chief Innovation Officer, Medical University of South Carolina

Dr. Jesse Goodwin

Jesse Goodwin, Ph.D., has spent more than a decade engaged in innovation across a broad range of medical therapies, with applications in academia and industry. She has a demonstrated track record for driving improved outcome metrics and process improvements that lead to increased transparency, efficiency and accountability. Prior to accepting the role of chief innovation officer at MUSC, Goodwin was vice president of development for the Zucker Institute for Applied Neurosciences, a technology accelerator working to develop and commercialize technologies generated by the department of Neurosciences at MUSC. Goodwin leads the therapeutics translation core for SCTR, and served as the deputy director for the MUSC Foundation for Research Development, the university’s technology transfer office responsible for managing intellectual property. Prior to joining MUSC, Goodwin was the director of the medical device practice of a Boston-based intellectual property consulting firm.

Prior to that, Dr. Goodwin completed a post-doctoral fellowship at the Harvard-MIT Division of Health Sciences and Technology, where she was awarded an NIH fellowship. She holds a Ph.D. in Biomedical Engineering from Stony Brook University.

womens-board-grace-powers

Vice President of Regulatory Affairs – Brookhaven Medical

Grace Powers

Grace Powers is the Vice President of Regulatory Affairs for Brookhaven Medical. She has fifteen years experience in cardiology and urology medical devices including R&D. She has management experience including RA responsibilities related to submissions and compliance. Her RA submission experience includes 510(k), IDE, PMA, HUD, EU Technical Files and Design Dossiers.

Grace previously has managed an International RA team which including Canadian licensing, Australia, Japan, China, Russia, Latin America and other country submissions. She has worked for C.R. Bard, CardioMEMS and Novoste. She also does regulatory consulting for universities, inventors and start-ups. Grace holds a BE in Biomedical Engineering from Vanderbilt University, a MS in Biomedical Engineering from UCLA and an MBA from Georgia Tech. She is RAC US, RAC Europe, and RAC Global certified.

Dr. Lauren Rashford

Lauren is currently serving as the Senior Director of Clinical Operations at Moterum Technologies. She holds a doctorate in physical therapy and brings substantial experience in the neuro-rehabilitation world, including clinical management and business development roles. With her strong background in both clinical and commercial rehabilitation she offers expertise in clinical strategy and integration. She has played a direct role in launch strategy, data integration, and research development. Lauren has been responsible for clinical operations, building and leveraging partnerships, and delivering current protocols/education. Additionally, Lauren will continue to cultivate, build and maintain relationships that help foster the clinical integration process.

Prior to her time at Moterum, Lauren specialized working with the neurologic population, specifically amputees and spinal cord injury. She also holds a BA in Education from Brandeis University, where she played college basketball.

Dr. Esra Roan

Dr. Esra Roan is the CEO and co-founder of SOMAVAC® Medical Solutions, Inc. Previously, she served as an Associate Professor in the Biomedical Engineering Department at the University of Memphis.  She had the opportunity to utilize her technical skills in diverse environments from industry and academia to small business. She began her career as a development engineer at 3M Precision Optics (Cincinnati, OH). In her academic role, Dr. Roan built a soft tissue and cell mechanics lab at the U of Memphis where she was recognized for her research with an Outstanding Early Career Investigator Award from the American Thoracic Society. She co-founded SOMAVAC Medical Solutions to design and commercialize medical technologies focusing on post-surgical recovery at home.

Dr. Roan has BS and MS degrees in Mechanical Engineering from the Tennessee Technological University (TTU) and a PhD in Mechanical Engineering from the University of Cincinnati. Dr. Roan’s path to the US was through a tennis scholarship at TTU, where she was recognized for her achievements with an introduction into the TTU Athletic Hall of Fame in 2011. She now lives in Memphis, TN with her husband Steve and two children (Ben and Emre).

woåmens-board-meredith-struby

Principal – Meunier Carlin & Curfman

Meredith Struby

Meredith has been a practicing patent attorney since 2003, focusing on mechanical, medical devices, and electro-mechanical systems. She advises large and small clients about protecting their innovations and other intellectual property and avoiding the intellectual property of others.

She has extensive experience preparing and prosecuting utility and design patent applications before the U.S. Patent and Trademark Office related to a variety of technology areas, including automotive, building materials, fasteners, children’s toys, medical devices, and textiles. She also works with universities on mechanical related inventions.

womens-board-jayne-morgan

Director of Cardiovascular Research – Piedmont Heart Institute

Jayne Morgan, Co-Chair

Dr. Jayne Morgan is a Cardiologist with extensive experience in clinical patient management, as well as pharmaceutical and biotech research. For the past 2 decades she has focused on improving the care and quality of life measures for patients from heterogenous populations, including end-of-life patients without further medical options.

Serving in the roles of both Clinical Development and Medical Affairs for global pharmaceutical and device companies for the past 10 years, she has successfully led Phase II and III programs globally, and Phase IV programs in Europe. In these roles, her background includes leadership and accountability for research projects with oversight of a $52 million dollar budget within a $4.5 billion company.

As the driver of the cardio-renal and heart failure programs (sponsored and funded by Solvay Pharmaceuticals), and providing the scientific guidance as a consultant to the MitraClip programs (funded and sponsored by Abbott Vascular), her experience in the design and execution of large international clinical trials for both devices and pharmaceuticals is well established. Acknowledged with both the Solvay Cardio-Metabolic Strategic Paper Award and People to People Ambassadorship for vulnerable global populations, she has selected and led many scientific panel experts including Steering Committees, Adjudication Committees, and Data Safety Monitoring Board Committees, and has also served on regulatory panels for both the FDA and EMA.

Following high school graduation as Valedictorian, Dr. Morgan went on to complete her B.S. degree in Biology and Biochemistry from Spelman College; her M.D. degree from Michigan State University; Internal Medicine Residency from George Washington University; and Cardiology Fellowship at Mount Sinai Medical Center including completion of a Pacemaker Sub-Fellowship. She has treated patients in both rural primary care settings, as well as within academic institutions as the Associate Professor of Medicine at the Cleveland Clinic Florida, and is published in both the American Heart Journal and recognized by the Heart Failure Society for her work on Adenosine Receptor Antagonists. Further, Dr. Morgan has received numerous distinctions in Principles of Radiation Physics, and RadioPharmaceuticals and Chemistry in Nuclear Medicine. In fact, most recently, she served as the CMO (Chief Medical Officer) of the American Chemistry Council where she introduced new stakeholders, advocated for senate bill reforms, and developed a strategy and new direction for their research program including securing funding from the Board of $5 million dollars annually for 4 years.

Dr. Morgan has also served as a 6 year Board member of the Make-A-Wish Foundation of Georgia and Alabama and the Calvary Childrens Home (orphanage). Currently, she is a Founding Member of Biotechnology for Women, member of the AHA (American Heart Association), AMA (American Medical Association), AWMA (American Womens Medical Association), and the ABC (Association of Black Cardiologists). Additionally, she is recognized as an Industry Fellow for the GRA (Georgia Research Alliance) focused on the development and commercialization of biotech and pharma innovations into viable companies and partnerships here in the state of Georgia.

Currently, she is the Director of Cardiovascular Research at the Piedmont Research Institute where she is responsible for all drug, device, and drug/device combination trials in both the Cardiovascular and Peripheral Vascular space. Bringing to an organization over 20+ years of clinical and industry experience, and a demonstrated record of strategic planning, management, and execution of trials to support the medical and scientific platform of an organization, Dr. Morgan is able to leverage a wealth of qualifications in business development, scientific rigor/conduct, medical education, and communication.